Updates matching "Cancer Research Funding"

Today the U.S. House of Representatives will begin debate on a package of funding bills for FY 2022, including funding for the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).

Washington, D.C. ---Today the House Appropriations Committee will vote on a proposed FY 2022 spending bill that would increase funding for the National Institutes of Health (NIH) by $6.5 billion and include a $432 million increase for the National Cancer Institute (NCI), and $194 million for the Cancer Moonshot.

AUSTIN, TX – June 23, 2021 – With Gov. Abbott’s signing of the fiscal year 2021 budget, the Texas Legislature renewed their commitment to appropriate funding for the Cancer Prevention and Research Institute of Texas (CPRIT), following a severe impact on cancer research and clinical trials as

The Biden administration released its budget for FY 22 late last week. Included in the budget is an additional $9 billion in funding for the National Institutes of Health (NIH), including $6.5 for the creation of a new department within the NIH called the Advanced Research Project Agency on Health (ARPA-H).

The American Cancer Society Cancer Action Network (ACS CAN) and the HL7 FHIR Accelerator™ Common Oncology Data Elements eXtensions (CodeX) are working together with partners on a project to increase and expand patient enrollment in cancer clinical trials at smaller and non-research oriented medical centers.

A new report from the American Cancer Society Cancer Action Network (ACS CAN) takes an in-depth look at disparities across all areas of cancer research and suggests immediate policy solutions that could help address such gaps in the years to come.

A group of more than fifty cancer research-focused organizations are urging Congress to include $10 billion in emergency funding to restart cancer research and clinical trials at the National Institutes of Health (NIH) stalled by the coronavirus pandemic.